The Opioid Crisis and Naloxone Pharmacy Access

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Branson MO: My Neighbor’s Charitable Pharmacy (NCP) will open its doors at 1232 Branson Hills Parkway February of 2023

Charitable Pharmacies of America organization member receives Health Equity grant

Using Public Health Detailing to Increase Access and Confidence in COVID-19 Vaccines and Reinvest in Disproportionately Impacted NYC Communities Go…

NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information

NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

Charitable Pharmacies of America organization member receives Health Equity grant

Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.